Erratum to: Is Extrapolation of the Safety and Efficacy Data in One Indication to Another Appropriate for Biosimilars?

Erratum to: AAPS J

DOI 10.1208/s12248-013-9534-y

Minor errors were published in Table II. The corrected Table II appears below.

Table II Efficacy of Infliximab in the Approved Indications